Parkinson disease

Insect screens for PD therapies — keep the flies in

Two new studies report on the potential of a number of antioxidants and a cholesterol-lowering drug to prevent neurodegeneration in a Drosophila genetic model of parkinsonism. This research shines a spotlight on the power of invertebrate models as an in vivo screening tool.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Angeles, D. C. et al. Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2. Ann. Clin. Transl. Neurol. 3, 288–294 (2016).

    CAS  Article  Google Scholar 

  2. 2

    Lin, C. H. et al. Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity. Hum. Mol. Genet. http://dx.doi.org/10.1093/hmg/ddw068 (2016).

  3. 3

    Whitworth, A. J. Drosophila models of Parkinson's disease. Adv. Genet. 73, 1–50 (2011).

    CAS  Article  Google Scholar 

  4. 4

    Healy, D. G. et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case–control study. Lancet Neurol. 7, 583–590 (2008).

    CAS  Article  Google Scholar 

  5. 5

    Simon-Sanchez, J. et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 41, 1308–1312 (2009).

    CAS  Article  Google Scholar 

  6. 6

    Smith, W. W. et al. Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat. Neurosci. 9, 1231–1233 (2006).

    CAS  Article  Google Scholar 

  7. 7

    West, A. B. et al. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl Acad. Sci. USA 102, 16842–16847 (2005).

    CAS  Article  Google Scholar 

  8. 8

    West, A. B. Ten years and counting: moving leucine-rich repeat kinase 2 inhibitors to the clinic. Mov. Disord. 30, 180–189 (2015).

    CAS  Article  Google Scholar 

  9. 9

    Huang, X. et al. Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study. Mov. Disord. 30, 552–559 (2015).

    CAS  Article  Google Scholar 

  10. 10

    Lin, C. H., Tsai, P. I., Wu, R. M. & Chien, C. T. LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3β. J. Neurosci. 30, 13138–13149 (2010).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Ian Martin.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Martin, I., Chittoor, V. Insect screens for PD therapies — keep the flies in. Nat Rev Neurol 12, 318–319 (2016). https://doi.org/10.1038/nrneurol.2016.56

Download citation

Further reading

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing